Linked Life Data

7903415

Source:http://linkedlifedata.com/resource/pubmed/id/7903415

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7903415rdf:typepubmed:Citationlld:pubmed
pubmed-article:7903415lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:7903415lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:7903415lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:7903415lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:7903415lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:7903415pubmed:issue6lld:pubmed
pubmed-article:7903415pubmed:dateCreated1994-1-26lld:pubmed
pubmed-article:7903415pubmed:abstractTextWith respect to the beta 1- and beta 2-adrenergic receptors (ARs), the beta 3-AR induces specific physiological effects in a few target tissues and exhibits atypical pharmacological properties that distinguish it unambiguously from its counterparts. Therefore, the beta 3-AR represents a suitable model to study the molecular mechanism responsible for receptor subtype selectivity and specificity. Potent beta 3-AR ligands newly characterized in Chinese hamster ovary cells expressing the beta 3-AR were also evaluated in Chinese hamster ovary cells expressing beta 1- and beta 2-ARs and were classified into three groups according to their pharmacological properties. Among the beta 1/beta 2/beta 3 agonists BRL 37344 and LY 79771 exhibit beta 3 selectivity in stimulating adenylyl cyclase; among the beta 1/beta 2 antagonists displaying beta 3 agonistic effects ICI 201651 exhibits beta 3-AR binding selectivity, whereas among the beta 1/beta 2/beta 3 antagonist class bupranolol is the most efficient (but not selective) beta 3-AR antagonist. The structures of these ligands were simulated and compared using computer-generated molecular modeling. Structure-activity relationship analysis indicates that potent or selective beta 3-AR compounds, in addition to possessing a pharmacophore common to all beta-AR ligands, contain a long and bulky alkylamine substituent moiety, which is able to adopt and exchange extended and stacked conformations. Computerized three-dimensional models of the beta 1-, beta 2-, and beta 3-AR binding sites show that more bulky amino acid side chains point inside the groove of the beta 1 and beta 2 sites, compared with the beta 3 site, in a region implicated in signal processing. The long alkylamine chain of compounds behaving as beta 1/beta 2 antagonists and beta 3 agonists may thus adopt either a stacked conformation in the encumbered beta 1- and beta 2-AR sites, leading to antagonistic effects, or an extended conformation in the less encumbered beta 3 site, thus interacting with specific residues implicated in signal transduction.lld:pubmed
pubmed-article:7903415pubmed:languageenglld:pubmed
pubmed-article:7903415pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903415pubmed:citationSubsetIMlld:pubmed
pubmed-article:7903415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7903415pubmed:statusMEDLINElld:pubmed
pubmed-article:7903415pubmed:monthDeclld:pubmed
pubmed-article:7903415pubmed:issn0026-895Xlld:pubmed
pubmed-article:7903415pubmed:authorpubmed-author:StrosbergA...lld:pubmed
pubmed-article:7903415pubmed:authorpubmed-author:MaigretBBlld:pubmed
pubmed-article:7903415pubmed:authorpubmed-author:BlinNNlld:pubmed
pubmed-article:7903415pubmed:authorpubmed-author:CamoinLLlld:pubmed
pubmed-article:7903415pubmed:issnTypePrintlld:pubmed
pubmed-article:7903415pubmed:volume44lld:pubmed
pubmed-article:7903415pubmed:ownerNLMlld:pubmed
pubmed-article:7903415pubmed:authorsCompleteYlld:pubmed
pubmed-article:7903415pubmed:pagination1094-104lld:pubmed
pubmed-article:7903415pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:meshHeadingpubmed-meshheading:7903415-...lld:pubmed
pubmed-article:7903415pubmed:year1993lld:pubmed
pubmed-article:7903415pubmed:articleTitleStructural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.lld:pubmed
pubmed-article:7903415pubmed:affiliationInstitut Cochin de Génétique Moléculaire, CNRS-UPR 0415, Paris, France.lld:pubmed
pubmed-article:7903415pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7903415pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7903415lld:pubmed